Welcome to the Next Generation Cardiovascular Drug Development Summit

Executing Cell & Gene Therapy for Cardiac Regeneration

Following technology advancements and the surge of investment in developing the next generation of cardiovascular disease drugs, the opportunity to successfully leverage our knowledge of CRISPR/Cas9, siRNA, autologous iPSC therapy, capsid engineering, and digital medicine to reduce the soaring fatality rate has never been closer.

The Next Generation Cardiovascular Drug Development Summit in Boston is the only industry-led summit committed to overcoming preclinical challenges to advance your ischemic heart disease, arrhythmogenic cardiomyopathy, strokes and hypertension pipelines.

To know more visit: https://ter.li/s7qk9l